Sialin expression in the CNS implicates extralysosomal function in neurons

Neurobiology of Disease

Volumn 15, Issue 2, 2004, Pages 251-261

  Aula, Nina ^a   Kopra, Outi ^a   Jalanko, Anu ^a   Peltonen, Leena ^a,b,c,d  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (Finland)

Author keywords

Axonal; Immunohistochemistry; In situ hybridization; Lysosomal membrane protein; Lysosome; Neuronal; Salla disease; Secretory process; Sialic acid transporter; Sialin

Indexed keywords

MEMBRANE PROTEIN; SIALIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GLIA CELL; HIPPOCAMPUS; LYSOSOME; MOUSE; NEOCORTEX; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; CELL DIFFERENTIATION; CELL MEMBRANE; CEREBRAL CORTEX; FETUS; HELA CELLS; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; LYSOSOMES; MICE; N-ACETYLNEURAMINIC ACID; NEURITES; NEUROGLIA; NEURONS; ORGANIC ANION TRANSPORTERS; PRESYNAPTIC TERMINALS; SIALIC ACID STORAGE DISEASE; SYMPORTERS;

EID: 1542330707     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2003.11.017     Document Type: Article

References (35)

1. Aula P., Gahl W. Disorders of free sialic acid storage. Scriver C.R.B.A., Sly W.S., Valle D. The Metabolic and Molecular Basis of Inherited Disease. vol. 3:2001;5109-5120 McGraw-Hill, New York.
2. Aula N., Salomaki P., Timonen R., Verheijen F., Mancini G., Mansson J.E., Aula P., Peltonen L. The spectrum of SLC17A5-gene mutations resulting in free sialic acid- storage diseases indicates some genotype-phenotype correlation. Am. J. Hum. Genet. 67:2000;832-840.
3. Aula N., Jalanko A., Aula P., Peltonen L. Unraveling the molecular pathogenesis of free sialic acid storage disorders: altered targeting of mutant sialin. Mol. Genet. Metab. 77:2002;99.
4. Autio-Harmainen H., Oldfors A., Sourander P., Renlund M., Dammert K., Simila S. Neuropathology of Salla disease. Acta Neuropathol. 75:1988;481-490.
5. Breitschopf H., Suchanek G., Gould R.M., Colman D.R., Lassmann H. In situ hybridization with digoxigenin-labeled probes: sensitive and reliable detection method applied to myelinating rat brain. Acta Neuropathol. 84:1992;581-587.
6. Carstea E.D., Morris J.A., Coleman K.G., Loftus S.K., Zhang D., Cummings C., Gu J.et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science. 277:1997;228-231.
7. Cherqui S., Kalatzis V., Trugnan G., Antignac C. The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif. J. Biol. Chem. 276:2001;13314-13321.
8. Consortium TIBD Isolation of a novel gene underlying Batten disease, CLN3. Cell. 82:1995;949-957.
9. Corvera S., Chawla A., Chakrabarti R., Joly M., Buxton J., Czech M.P. A double leucine within the GLUT4 glucose transporter COOH-terminal domain functions as an endocytosis signal. J. Cell Biol. 126:1994;979-989.
10. Del Rio J.A., Martinez A., Auladell C., Soriano E. Developmental history of the subplate and developing white matter in the murine neocortex. Neuronal organization and relationship with the main afferent systems at embryonic and perinatal stages. Cereb. Cortex. 10:2000;784-801.
11. Eskelinen E.L., Tanaka Y., Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 13:2003;137-145.
12. Fois A., Balestri P., Farnetani M.A., Mancini G.M., Borgogni P., Margollicci M.A., Molinelli M., Alessandrini C., Gerli R. Free sialic acid storage disease. A new Italian case. Eur. J. Pediatr. 146:1987;195-198.
13. Gahl W.A., Thoene J.G., Schneider J.A. Cystinosis. N. Engl. J. Med. 347:2002;111-121.
14. Gibson U.E., Heid C.A., Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res. 6:1996;995-1001.
15. Haataja L., Parkkola R., Sonninen P., Vanhanen S.L., Schleutker J., Aarimaa T., Turpeinen U., Renlund M., Aula P. Phenotypic variation and magnetic resonance imaging (MRI) in Salla disease, a free sialic acid storage disorder. Neuropediatrics. 25:1994;238-244.
16. Havelaar A.C., Beerens C.E., Mancini G.M., Verheijen F.W. Transport of organic anions by the lysosomal sialic acid transporter: a functional approach towards the gene for sialic acid storage disease. FEBS Lett. 446:1999;65-68.
17. Hazuka C.D., Foletti D.L., Hsu S.C., Kee Y., Hopf F.W., Scheller R.H. The sec6/8 complex is located at neurite outgrowth and axonal synapse-assembly domains. J. Neurosci. 19:1999;1324-1334.
18. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986-994.
19. Heinonen O., Kyttala A., Lehmus E., Paunio T., Peltonen L., Jalanko A. Expression of palmitoyl protein thioesterase in neurons. Mol. Genet. Metab. 69:2000;123-129.
20. Le Borgne R., Hoflack B. Protein transport from the secretory to the endocytic pathway in mammalian cells. Biochim. Biophys. Acta. 1404:1998;195-209.
21. Linnankivi T., Lonnqvist T., Autti T. A case of Salla disease with involvement of the cerebellar white matter. Neuroradiology. 45:2003;107-109.
22. Luiro K., Kopra O., Lehtovirta M., Jalanko A. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. Hum. Mol. Genet. 10:2001;2123-2131.
23. Mancini G.M., de Jonge H.R., Galjaard H., Verheijen F.W. Characterization of a proton-driven carrier for sialic acid in the lysosomal membrane. Evidence for a group-specific transport system for acidic monosaccharides. J. Biol. Chem. 264:1989;15247-15254.
24. Marks Michael S.O.H., Kirchhausen T., Bonifacino J.S. Protein sorting by tyrosine-based signals: adapting to the Ys and wherefores. Trends Cell Biol. 7:1997;124-128.
25. Nishino I., Fu J., Tanji K., Yamada T., Shimojo S., Koori T., Mora M., Riggs J.E., Oh S.J., Koga Y., Sue C.M., Yamamoto A., Murakami N., Shanske S., Byrne E., Bonilla E., Nonaka I., DiMauro S., Hirano M. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature. 406:2000;906-910.
26. Ohno H., Stewart J., Fournier M.C., Bosshart H., Rhee I., Miyatake S., Saito T., Gallusser A., Kirchhausen T., Bonifacino J.S. Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science. 269:1995;1872-1875.
27. Renlund M., Tietze F., Gahl W.A. Defective sialic acid egress from isolated fibroblast lysosomes of patients with Salla disease. Science. 232:1986;759-762.
28. Robinson R.O., Fensom A.H., Lake B.D. Salla disease - rare or underdiagnosed? Dev. Med. Child Neurol. 39:1997;153-157.
29. Schleutker J., Leppanen P., Mansson J.E., Erikson A., Weissenbach J., Peltonen L., Aula P. Lysosomal free sialic acid storage disorders with different phenotypic presentations - infantile-form sialic acid storage disease and Salla disease - represent allelic disorders on 6q14-15. Am. J. Hum. Genet. 57:1995;893-901.
30. Sonninen P., Autti T., Varho T., Hamalainen M., Raininko R. Brain involvement in Salla disease. Am. J. Neuroradiol. 20:1999;433-443.
31. Stacey A., Schnieke A. SVpoly: a versatile mammalian expression vector. Nucleic Acids Res. 18:1990;2829.
32. Town M., Jean G., Cherqui S., Attard M., Forestier L., Whitmore S.A., Callen D.F., Gribouval O., Broyer M., Bates G.P., van't Hoff W., Antignac C. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat. Genet. 18:1998;319-324.
33. 1H MRS of the brain in Salla disease. Neurology. 52:1999;1668-1672.
34. Verheijen F.W., Verbeek E., Aula N., Beerens C.E., Havelaar A.C., Joosse M., Peltonen L., Aula P., Galjaard H., van der Spek P.J., Mancini G.M. A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nat. Genet. 23:1999;462-465.
35. +-coupled electrogenic lysosomal amino acid transporter LYAAT1 localizes to the axon and plasma membrane of hippocampal neurons. J. Neurosci. 23:2003;1265-1275.